Comparative Analysis of Gene Expression in Fibroblastic Foci in Patients with Idiopathic Pulmonary Fibrosis and Pulmonary Sarcoidosis
暂无分享,去创建一个
T. Welte | F. Laenger | M. Hoeper | A. Haverich | D. Jonigk | J. Gottlieb | L. Neubert | P. Braubach | J. Hinrichs | F. Ius | A. Seidel | H. Stark | M. Kuehnel | J. Kamp | C. Boekhoff
[1] Hongying Zhao,et al. Identification of common signatures in idiopathic pulmonary fibrosis and lung cancer using gene expression modeling , 2020, BMC cancer.
[2] K. Izuhara,et al. Plasma matrix metalloproteinase 7, CC-chemokine ligand 18, and periostin as markers for pulmonary sarcoidosis. , 2020, Respiratory investigation.
[3] Dongfeng Chen,et al. Src family kinases and pulmonary fibrosis: A review. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[4] M. Jamal-Hanjani,et al. Transcriptome analysis of IPF fibroblastic foci identifies key pathways involved in fibrogenesis , 2020, Thorax.
[5] D. Riches,et al. Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases , 2019, European Respiratory Journal.
[6] Wande Li,et al. LOX/LOXL in pulmonary fibrosis: potential therapeutic targets , 2018, Journal of drug targeting.
[7] F. Länger,et al. Schädigungsmuster interstitieller Lungenerkrankungen , 2018, Der Pathologe.
[8] Takeshi Johkoh,et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline , 2018, American journal of respiratory and critical care medicine.
[9] E. White,et al. Correction: Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis (doi: 10.1242/dmm.030114) , 2017, Disease Models & Mechanisms.
[10] D. Lynch,et al. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. , 2017, The Lancet. Respiratory medicine.
[11] Seidai Sato,et al. Lysyl Oxidase‐Like 1 Protein Deficiency Protects Mice from Adenoviral Transforming Growth Factor‐&bgr;1‐induced Pulmonary Fibrosis , 2017, American journal of respiratory cell and molecular biology.
[12] E. White,et al. Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis , 2017, Disease Models & Mechanisms.
[13] T. Welte,et al. Comparative analysis of morphological and molecular motifs in bronchiolitis obliterans and alveolar fibroelastosis after lung and stem cell transplantation , 2016, The journal of pathology. Clinical research.
[14] S. Benvenuti,et al. Ockham’s razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer , 2016, Journal of Translational Medicine.
[15] J. Myers,et al. Histopathology of Explanted Lungs From Patients With a Diagnosis of Pulmonary Sarcoidosis. , 2016, Chest.
[16] O. Sokhatska,et al. Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias. , 2015, Respiratory medicine.
[17] G. Rossi,et al. Pathology of Sarcoidosis , 2015, Clinical Reviews in Allergy & Immunology.
[18] A. Günther,et al. The role of tyrosine kinases in the pathogenesis of idiopathic pulmonary fibrosis , 2015, European Respiratory Journal.
[19] Alexander Pautsch,et al. Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis , 2015, European Respiratory Journal.
[20] Gang Liu,et al. Therapeutic Targeting of Src Kinase in Myofibroblast Differentiation and Pulmonary Fibrosis , 2014, The Journal of Pharmacology and Experimental Therapeutics.
[21] M. Falasca,et al. Role of phospholipase C in cell invasion and metastasis. , 2013, Advances in biological regulation.
[22] J. Distler,et al. Tyrosine kinase signaling in fibrotic disorders: Translation of basic research to human disease. , 2013, Biochimica et biophysica acta.
[23] H. Iwasaki,et al. Prognostic significance of fibroblastic foci in usual interstitial pneumonia and non‐specific interstitial pneumonia , 2013, Respirology.
[24] R. Baughman,et al. A concise review of pulmonary sarcoidosis. , 2011, American journal of respiratory and critical care medicine.
[25] Lei Zhou,et al. [Change of matrix metalloproteinase-1 and matrix metalloproteinase-7 in serum and bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and sarcoidosis]. , 2010, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.
[26] Naftali Kaminski,et al. MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis , 2008, PLoS medicine.
[27] P. Piirilä,et al. Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[28] Alok Tomar,et al. Obligatory role for phospholipase C-γ1 in villin-induced epithelial cell migration , 2007 .
[29] Ling Zhu,et al. TGF-β-regulated collagen type I accumulation: role of Src-based signals , 2007 .
[30] S. Gilpin,et al. Cell-specific gene expression in patients with usual interstitial pneumonia. , 2006, American journal of respiratory and critical care medicine.
[31] Richard O Hynes,et al. Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.
[32] Naftali Kaminski,et al. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[33] W. Travis,et al. Nonspecific interstitial pneumonia (NSIP). , 2001, Seminars in respiratory and critical care medicine.
[34] J. Myers,et al. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. , 1998, American journal of respiratory and critical care medicine.
[35] A. Churg,et al. Pathology of Chronic Hypersensitivity Pneumonitis What Is It? What Are the Diagnostic Criteria? Why Do We Care? , 2018, Archives of pathology & laboratory medicine.
[36] Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis. , 2015, The New England journal of medicine.
[37] S. Rosselot. Idiopathic pulmonary fibrosis. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[38] Takeshi Johkoh,et al. American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .
[39] R. Govindarajan,et al. Pulmonary sarcoidosis. , 1985, The Journal of the Association of Physicians of India.